由5-甲诱导的急性心脏毒性成功用levosimendan治疗:一个病例报告
Carlos Wu-Chin1, Carlos Zúñiga-Orlich2, Juliana Salas-Segura3
1Critical Care Medicine, Hospital Clínica Bíblica, San José, CRI.
Cureus
|September 15, 2025
概括
这项案例研究表明,levosimendan有效地治疗了由5-fluorouracil化疗引起的急性心力衰竭. 治疗改善了心脏功能和生物标志物,证明了其在管理化疗相关心脏毒性的潜力.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 五甲 (5-FU) 化疗可以引起罕见但严重的心脏毒性,通常呈现为急性心力衰竭.
- 化疗诱导的心脏毒性是一个重大的临床挑战,需要及时诊断和管理.
研究的目的:
- 报告急性不补偿性心力衰竭的病例,这是5-FU化疗的次要原因.
- 评估levosimendan在治疗化疗相关心脏毒性的疗效.
主要方法:
- 一名患有结肠癌的患者在folfox化疗后出现急性心力衰竭.
- 心声和心脏生物标志物 (pro-BNP) 用于诊断.
- 治疗包括持续的levosimendan输液和北上腺素支持.
主要成果:
- 患者经历了显著的临床改善和心脏生物标志物的正常化.
- 心声图显示左心室喷射分数 (LVEF) 从28%恢复到50%.
- 排除了心脏功能障碍的其他潜在原因.
结论:
- 利沃西门丹可能是化学疗法诱导的心脏毒性治疗的有益治疗选择,需要以诺托普的支持.
- 需要进一步的临床研究,以建立基于证据的指导方针,在这种情况下使用levosimendan.
相关概念视频
Heart Failure Drugs: Inotropic Agents
1.3K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.3K
Cardiomyopathy VI: Nursing Management
314
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
314
Heart Failure Drugs: Diuretics
809
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
809
Heart Failure III: Clinical Manifestations
511
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
511
Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223


